相关实验视频

Updated: Sep 9, 2025

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

在基底类乳腺癌中,特定亚型的HER3丰富通过GATA2/GATA3-FOXA1轴进行调节

Congcong Tan¹, Hui Lyu¹, Sanbao Ruan¹

¹Departments of Interdisciplinary Oncology and Genetics, Stanley S. Scott Cancer Center, School of Medicine, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA.

|September 4, 2025

概括

基因脱乙酶抑制剂通过降低HER3信号来选择性向基底类乳腺癌 (BLBC). 这项研究确定了一种新的GATA2/GATA3-FOXA1-HER3轴,对BLBC进展和治疗反应至关重要.

科学领域:

癌症学
分子生物学
癌症基因组学

背景情况:

基础性乳腺癌 (BLBC) 是三阴性乳腺癌 (TNBC) 的一个亚型,具有攻击性行为和有限的治疗选择.
在TNBC中HER3过度表达与不良结果相关,但其在BLBC亚型和治疗向中的具体作用仍未得到充分研究.

研究的目的:

研究HER3信号在BLBC中的特定作用.
在BLBC中探索基因组脱乙酶抑制剂 (HDACi) 的治疗潜力.
阐明调节BLBC中的HER3表达的分子机制.

主要方法:

转录基因分析以比较BLBC和低克劳丁度乳腺癌 (CLBC) 中的HER3信号.
在体外和体内使用HDAC抑制剂 (罗米德普辛,帕诺比诺斯塔特),基因倒置和过度表达的研究.
染色体免疫沉测试以确认转录因子的结合.

主要成果:

在BLBC中,HER3信号被选择性地过度激活.
通过降低HER3的调节,HDACi (罗米德普辛,帕诺宾) 在BLBC中表现出强大的抗瘤作用.
发现了一种新的GATA2/ GATA3- FOXA1- HER3调节轴,对BLBC进展至关重要.
在BLBC患者中,高表达的GATA2,GATA3,FOXA1或HER3与预后不佳相关.

结论:

GATA2/GATA3-FOXA1-HER3轴是BLBC进展的一个关键驱动器.
HDAC抑制剂Romidepsin和Panobinostat对BLBC具有显著的治疗潜力,并且可以重新用于治疗.

关键词:

一个BLBC 其他类型其他类型在 GATA 其他国家没有.在HER3中

更多相关视频

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on: December 5, 2017

Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples

Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples

Published on: October 2, 2020

相关概念视频

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...